Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic Study of JTE-061 Cream in Atopic Dermatitis
jRCT2011210062Completed
- Sponsor
- Japan Tobacco
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tapinarof in atopic dermatitis (AD) (2 arms), sponsored by Japan Tobacco. Primary endpoints: Change in stratum corneum hydration at Week 8 and Change in transepidermal water loss at Week 8. Started Apr 2022; status: completed.
02
Drugs
tapinarof
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2011210062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2011210062.